Related references
Note: Only part of the references are listed.The changing face of neural stem cell therapy in neurologic diseases
Ofira Einstein et al.
ARCHIVES OF NEUROLOGY (2008)
Hematopoietic cell transplantation for patients with myelodysplastic syndromes (MDS): When, how and for whom?
Mario Marcondes et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2008)
Incorporating hematopoietic cell transplantation (HCT) into the management of adults aged under 60 years with acute myeloid leukemia (AML)
Frederick R. Appelbaum
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2008)
Hematopoietic stem cell transplantation in adults with acute myeloid leukemia
Mehdi Hamadani et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Cell therapy for ischaemic heart disease
Saskia L. M. A. Beeres et al.
HEART (2008)
Matched Unrelated or Matched Sibling Donors Result in Comparable Survival After Allogeneic Stem-Cell Transplantation in Elderly Patients With Acute Myeloid Leukemia: A Report From the Cooperative German Transplant Study Group
Johannes Schetelig et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Stem cell therapy in myocardial repair and remodeling
Nathan M. Novotny et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2008)
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease:: a phase II study
Katarina LeBlanc et al.
LANCET (2008)
Allogeneic stem cell transplantation for myelodysplastic syndrome
A. John Barrett et al.
SEMINARS IN HEMATOLOGY (2008)
The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products
A. Gratwohl et al.
BONE MARROW TRANSPLANTATION (2008)
Predictability of hematopoietic stem cell transplantation rates
Alois Gratwohl et al.
HAEMATOLOGICA (2007)
Donor lymphocyte infusion in the treatment of first Hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia:: A retrospective risk factors analysis and comparison with other strategies by the EBMT acute leukemia working party
Christoph Schmid et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?
Jan J. Cornelissen et al.
BLOOD (2007)
From the laboratory bench to the patients bedside: An update on clinical trials with mesenchymal stem cells
Antonio Giordano et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: focus on increasing use of unrelated donors
A. Gratwohl et al.
BONE MARROW TRANSPLANTATION (2007)
Stem cells and rheumatology: Update on adult stem cell therapy in autoimmune diseases
Alan Tyndall et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2006)
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe
P Ljungman et al.
BONE MARROW TRANSPLANTATION (2006)
Donor leukocyte infusions after unrelated donor hematopoietic stem cell transplantation
AW Loren et al.
CURRENT OPINION IN ONCOLOGY (2006)
Clarification of the nomenclature for MSC: The international society for cellular therapy position statement
EM Horwitz et al.
CYTOTHERAPY (2005)
Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003
A Gratwohl et al.
BONE MARROW TRANSPLANTATION (2005)
Current trends in hematopoietic stem cell transplantation in Europe
A Gratwohl et al.
BLOOD (2002)
Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose
C Guglielmi et al.
BLOOD (2002)
Economics, health care systems and utilization of haematopoietic stem cell transplants in Europe
A Gratwohl et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Share Paper
